CHEN Zhi-yu, LI Ying. Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
|
Citation:
|
CHEN Zhi-yu, LI Ying. Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
|
CHEN Zhi-yu, LI Ying. Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
|
Citation:
|
CHEN Zhi-yu, LI Ying. Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
|
DownLoad: